Skip to main content
. 2020 Nov 25;8(2):e001558. doi: 10.1136/jitc-2020-001558

Table 2.

Comparison of PD-L1 positivity in primary versus metastatic sites

Tissue PD-L1+ immune cell PD-L1− immune cell P value PD-L1+ tumor cell PD-L1− tumor cell P value
Primary 114 65 0.0001 15 164 0.1313
Metastasis 68 93 7 154

PD-L1, Programmed Death Ligand 1.